Catalyst Wire Dossier Catalyst Wire Dossier

rBV A/B

recombinant botulinum neurotoxin type A/B
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rBV A/B, covering 2025-06-13 to 2025-06-13. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG® [Phase 2]

See pricing